BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9610866)

  • 1. The prognostic significance of c-myc oncogene expression in uveal melanoma.
    Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
    Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic importance of c-myc oncogene expression in head and neck melanoma.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Ann Plast Surg; 2001 Aug; 47(2):172-7. PubMed ID: 11506326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma.
    Grover R; Ross DA; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma.
    Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oncogene expression as an independent prognostic marker for primary melanoma.
    Grover R; Pacifico MD; Wilson GD; Sanders R
    Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
    Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
    Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma.
    Ramsden AJ; Grover R; Chana J; Tulley P; Sanders R; Wilson GD
    J Plast Reconstr Aesthet Surg; 2007; 60(6):626-30. PubMed ID: 17485049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
    Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
    Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.
    Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K
    J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
    Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
    Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of c-myc oncogene expression in melanomas of the scalp.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of oncogene expression in subungual melanoma.
    Grover R; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Jan; 50(1):15-9. PubMed ID: 9038509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between c-myc expression and interferon sensitivity in uveal melanoma.
    Tulley PN; Neale M; Jackson D; Chana JS; Grover R; Cree I; Grobbelaar AO; Wilson GD
    Br J Ophthalmol; 2004 Dec; 88(12):1563-7. PubMed ID: 15548813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up.
    Seregard S; Kock E
    Acta Ophthalmol Scand; 1995 Aug; 73(4):340-4. PubMed ID: 8646581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
    Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
    Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
    Seregard S; Spångberg B; Juul C; Oskarsson M
    Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.
    Damato B; Coupland SE
    Eye (Lond); 2009 Dec; 23(12):2152-60; quiz 2161-2. PubMed ID: 19876071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does NEMO/IKKγ protein have a role in determining prognostic significance in uveal melanoma?
    Singh MK; Pushker N; Meel R; Chodsol K; Sen S; Bakhshi S; Singh L; Kashyap S
    Clin Transl Oncol; 2018 Dec; 20(12):1592-1603. PubMed ID: 29796997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-myc oncogene expression in ocular melanomas.
    Royds JA; Sharrard RM; Parsons MA; Lawry J; Rees R; Cottam D; Wagner B; Rennie IG
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):366-71. PubMed ID: 1505770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.